Position in RYTM
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$6,075,550
-$1,546,982 QoQ
Shares Held
69,858
-1.9% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 25.382919636977867.ToString("F0")%
Shared 0.ToString("F0")%
None 74.61708036302213.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,238,262,141 across 282 Biotechnology names. RYTM ranks #35 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in RYTM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,075,550 | 69,858 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,622,532 | 71,212 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,288,047 | 82,068 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $5,530,767 | 87,526 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,540,535 | 85,719 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $4,631,281 | 82,731 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $4,228,606 | 80,714 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,410,566 | 83,063 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,324,450 | 76,724 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,363,716 | 73,172 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,684,047 | 73,459 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,147,671 | 69,598 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $655,971 | 56,942 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $604,159 | 60,537 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $800,408 | 61,287 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,194,614 | 61,012 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $854,096 | 40,155 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,236,113 | 41,578 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $838,910 | 38,713 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $995,204 | 44,628 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $525,150 | 34,504 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||